Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NAVB - Navidea Biopharmaceuticals Inc

Previous close
0.001
0   0%

Share volume: 1,836,193
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30
Fiscal Quarter Q1 2022 Q2 2022
Report Date 2022-05-16 2022-08-15
Total revenue 0.000 57.526 K
Cost of revenue 0.000 473.000
Gross profit 0.000 57.053 K
    inf%  
Operating expenses 2.979 M 2.980 M
Selling general and admin 1.810 M 1.256 M
Research and development 1.169 M 1.724 M
Total expenses 2.979 M 2.980 M
    0.03%  
Operating income -2.979 M -2.923 M
Ebit -2.979 M -2.923 M
Pretax income -2.987 M -2.999 M
    0.41%  
Income tax 0.000 0.000
Net income basic -2.987 M -2.999 M
    -0.41%  
Net income -2.987 M -2.999 M
    -0.41%